Tae Won Kim

Cross-Sectional Study of Imatinib Plasma Trough Levels in Patients With Advanced Gastrointestinal Stromal Tumors: Impact of Gastrointestinal Resection on Exposure to Imatinib

Changhoon Yoo, Min‐Hee Ryu, Byung Woog Kang et al. · Journal of Clinical Oncology · 2010 · 90 citations

Medicine, Clinical Pharmacokinetics, Pharmacokinetics +9

Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer

Jin Cheon Kim, Ye Jin Ha, Ka Hee Tak et al. · PLoS ONE · 2016 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +17

Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability‒High Colon Cancer

Jaewon Hyung, Eun Jeong Cho, Jihun Kim et al. · Cancer Research and Treatment · 2022 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies

Kyu‐pyo Kim, Seongjoon Park, Jeongeun Kim et al. · Investigational New Drugs · 2015 · 23 citations

Medicine, Pharmacokinetics, Pharmacology +11

Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors: correlation between changes in covariates and imatinib exposure

Changhoon Yoo, Min‐Hee Ryu, Baek‐Yeol Ryoo et al. · Investigational New Drugs · 2011 · 19 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +8